Literature DB >> 23264048

Complex T cell interactions contribute to Helicobacter pylori gastritis in mice.

Brian M Gray1, Clinton A Fontaine, Sara A Poe, Kathryn A Eaton.   

Abstract

Disease due to the gastric pathogen Helicobacter pylori varies in severity from asymptomatic to peptic ulcer disease and cancer. Accumulating evidence suggests that one source of this variation is an abnormal host response. The goal of this study was to use a mouse model of H. pylori gastritis to investigate the roles of regulatory T cells (Treg) as well as proinflammatory T cells (Th1 and Th17) in gastritis, gastric T cell engraftment, and gastric cytokine production. Our results support published data indicating that severe gastritis in T cell recipient mice is due to failure of Treg engraftment, that Treg ameliorate gastritis, and that the proinflammatory response is attributable to interactions between several cell subsets and cytokines. We confirmed that gamma interferon (IFN-γ) is essential for induction of gastritis but showed that IFN-γ-producing CD4 T cells are not necessary. Interleukin 17A (IL-17A) also contributed to gastritis, but to a lesser extent than IFN-γ. Tumor necrosis factor alpha (TNF-α) and IL-17F were also elevated in association with disease. These results indicate that while H. pylori-specific CD4(+) T cells and IFN-γ are both essential for induction of gastritis due to H. pylori, IFN-γ production by T cells is not essential. It is likely that other proinflammatory cytokines, such as IL-17F and TNF-α, shown to be elevated in this model, also contribute to the induction of disease. We suggest that gastritis due to H. pylori is associated with loss of immunoregulation and alteration of several cytokines and cell subsets and cannot be attributed to a single immune pathway.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23264048      PMCID: PMC3584856          DOI: 10.1128/IAI.01269-12

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  53 in total

1.  DC-derived IL-18 drives Treg differentiation, murine Helicobacter pylori-specific immune tolerance, and asthma protection.

Authors:  Mathias Oertli; Malin Sundquist; Iris Hitzler; Daniela B Engler; Isabelle C Arnold; Sebastian Reuter; Joachim Maxeiner; Malin Hansson; Christian Taube; Marianne Quiding-Järbrink; Anne Müller
Journal:  J Clin Invest       Date:  2012-02-06       Impact factor: 14.808

2.  Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements.

Authors:  M J Barnden; J Allison; W R Heath; F R Carbone
Journal:  Immunol Cell Biol       Date:  1998-02       Impact factor: 5.126

3.  IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis.

Authors:  Yutaka Komiyama; Susumu Nakae; Taizo Matsuki; Aya Nambu; Harumichi Ishigame; Shigeru Kakuta; Katsuko Sudo; Yoichiro Iwakura
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

4.  The role of T cell subsets and cytokines in the pathogenesis of Helicobacter pylori gastritis in mice.

Authors:  K A Eaton; M Mefford; T Thevenot
Journal:  J Immunol       Date:  2001-06-15       Impact factor: 5.422

5.  A regulatory instead of an IL-17 T response predominates in Helicobacter pylori-associated gastritis in children.

Authors:  Fabrício Freire de Melo; Andreia Maria Camargos Rocha; Gifone Aguiar Rocha; Silvia Helena Sousa Pietra Pedroso; Sérgio de Assis Batista; Lúcia Porto Fonseca de Castro; Simone Diniz Carvalho; Paulo Fernando Souto Bittencourt; Celso Afonso de Oliveira; Rodrigo Corrêa-Oliveira; Dulciene Maria Magalhães Queiroz
Journal:  Microbes Infect       Date:  2011-11-25       Impact factor: 2.700

6.  Helicobacter pylori directs tolerogenic programming of dendritic cells.

Authors:  Min Zhang; Maochang Liu; Jay Luther; John Y Kao
Journal:  Gut Microbes       Date:  2010-07-16

7.  Role of tumor necrosis factor-alpha and interferon-gamma in Helicobacter pylori infection.

Authors:  Toshiro Yamamoto; Masakazu Kita; Tomoyuki Ohno; Yoichiro Iwakura; Kenji Sekikawa; Jiro Imanishi
Journal:  Microbiol Immunol       Date:  2004       Impact factor: 1.955

8.  Adoptive transfer of splenocytes in SCID mice implicates CD4+ T cells in apoptosis and epithelial proliferation associated with Helicobacter pylori-induced gastritis.

Authors:  Richard A Peterson; Toni Hoepf; Kathryn A Eaton
Journal:  Comp Med       Date:  2003-10       Impact factor: 0.982

9.  Helicobacter pylori stimulates a mixed adaptive immune response with a strong T-regulatory component in human gastric mucosa.

Authors:  Rasmus Goll; Franz Gruber; Trine Olsen; Guanglin Cui; Gabriele Raschpichler; Magne Buset; Anne M Asfeldt; Anne Husebekk; Jon Florholmen
Journal:  Helicobacter       Date:  2007-06       Impact factor: 5.753

10.  Anti-inflammatory effects of IL-17A on Helicobacter pylori-induced gastritis.

Authors:  Koji Otani; Toshio Watanabe; Tetsuya Tanigawa; Hirotoshi Okazaki; Hirokazu Yamagami; Kenji Watanabe; Kazunari Tominaga; Yasuhiro Fujiwara; Nobuhide Oshitani; Tetsuo Arakawa
Journal:  Biochem Biophys Res Commun       Date:  2009-02-26       Impact factor: 3.575

View more
  23 in total

Review 1.  Th17 Cells in Helicobacter pylori Infection: a Dichotomy of Help and Harm.

Authors:  Beverly R E A Dixon; Rafat Hossain; Rachna V Patel; Holly M Scott Algood
Journal:  Infect Immun       Date:  2019-10-18       Impact factor: 3.441

Review 2.  At the Bench: Helicobacter pylori, dysregulated host responses, DNA damage, and gastric cancer.

Authors:  Dana M Hardbower; Richard M Peek; Keith T Wilson
Journal:  J Leukoc Biol       Date:  2014-05-27       Impact factor: 4.962

Review 3.  Structural modifications of Helicobacter pylori lipopolysaccharide: an idea for how to live in peace.

Authors:  Magdalena Chmiela; Eliza Miszczyk; Karolina Rudnicka
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

4.  Epidermal growth factor receptor inhibition downregulates Helicobacter pylori-induced epithelial inflammatory responses, DNA damage and gastric carcinogenesis.

Authors:  Johanna C Sierra; Mohammad Asim; Thomas G Verriere; M Blanca Piazuelo; Giovanni Suarez; Judith Romero-Gallo; Alberto G Delgado; Lydia E Wroblewski; Daniel P Barry; Richard M Peek; Alain P Gobert; Keith T Wilson
Journal:  Gut       Date:  2017-05-04       Impact factor: 23.059

5.  IL-17 Receptor Signaling through IL-17A or IL-17F Is Sufficient to Maintain Innate Response and Control of Helicobacter pylori Immunopathogenesis.

Authors:  Beverly R E A Dixon; Tiffany J Lee; Diana C Contreras Healey; Jing Li; Jeremy A Goettel; M Blanca Piazuelo; Holly M Scott Algood
Journal:  Immunohorizons       Date:  2022-02-10

6.  CagY Is an Immune-Sensitive Regulator of the Helicobacter pylori Type IV Secretion System.

Authors:  Roberto M Barrozo; Lori M Hansen; Anna M Lam; Emma C Skoog; Miriam E Martin; Lucy P Cai; Yong Lin; Andreas Latoscha; Sebastian Suerbaum; Don R Canfield; Jay V Solnick
Journal:  Gastroenterology       Date:  2016-08-26       Impact factor: 22.682

Review 7.  T Cell Cytokines Impact Epithelial Cell Responses during Helicobacter pylori Infection.

Authors:  Holly M Scott Algood
Journal:  J Immunol       Date:  2020-03-15       Impact factor: 5.422

Review 8.  Systems-wide analyses of mucosal immune responses to Helicobacter pylori at the interface between pathogenicity and symbiosis.

Authors:  Barbara Kronsteiner; Josep Bassaganya-Riera; Casandra Philipson; Monica Viladomiu; Adria Carbo; Vida Abedi; Raquel Hontecillas
Journal:  Gut Microbes       Date:  2016

9.  Interleukin- 17agene Polymorphism, Serum Level and Its Tissue Expression in Iraqi Patients Gastric Lesions.

Authors:  Haider F Ghazi; Manar Mustafa; Hayfaa M Fahad
Journal:  Med Arch       Date:  2021-02

10.  Efficacy of the antimicrobial peptide TP4 against Helicobacter pylori infection: in vitro membrane perturbation via micellization and in vivo suppression of host immune responses in a mouse model.

Authors:  Jayaram Lakshmaiah Narayana; Han-Ning Huang; Chang-Jer Wu; Jyh-Yih Chen
Journal:  Oncotarget       Date:  2015-05-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.